ZETA : Prospective Observational Study
NCT03730558
·
clinicaltrials.gov ↗
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Colon Cancer
Interventions
COMBINATION_PRODUCT:
aflibercept + FOLFIRI
Sponsor
Recherche clinique